Cortland Manor, NY, United States of America

Carolyn M Paradise

USPTO Granted Patents = 3 


Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 38(Granted Patents)


Company Filing History:


Years Active: 2006-2008

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Carolyn M Paradise

Introduction

Carolyn M Paradise is a notable inventor based in Cortland Manor, NY (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of pharmaceutical compositions. With a total of three patents to her name, her work focuses on methods of treating cancer using HDAC inhibitors.

Latest Patents

Paradise's latest patents revolve around the methods of treating cancer with HDAC inhibitors. These inventions provide methods for treating various cancers, chemoprevention, and selectively inducing terminal differentiation, cell growth arrest, and apoptosis of neoplastic cells. The pharmaceutical compositions she developed demonstrate surprisingly high oral bioavailability of the active compounds. Furthermore, these compositions yield high, therapeutically effective blood levels of the active compounds over an extended period. The inventions also include a safe, daily dosing regimen that is easy to follow, ensuring a therapeutically effective amount of HDAC inhibitors in vivo.

Career Highlights

Throughout her career, Carolyn M Paradise has worked with prominent organizations such as Merck HDAC Research, LLC and the Sloan-Kettering Institute for Cancer Research. Her experience in these institutions has allowed her to advance her research and contribute to the development of effective cancer treatments.

Collaborations

Some of her notable coworkers include Judy H Chiao and Nicholas G Bacopoulos. Their collaboration has likely played a role in enhancing the research and development of innovative cancer therapies.

Conclusion

Carolyn M Paradise's work in the field of cancer treatment through HDAC inhibitors showcases her dedication to innovation and improving patient outcomes. Her contributions are significant in the ongoing fight against cancer, and her patents reflect her commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…